000			04420nam a22004695i 4500
001			978-3-319-42139-1
003			DE-He213
005			20180206182938.0
007			cr nn 008mamaa
008			160913s2016 gw | s |||| 0|eng d
020			_a9783319421391 _9978-3-319-42139-1
050		4	_aQP356.3
072		7	_aMJN _2bicssc
072		7	_aMED057000 _2bisacsh
082	0	4	_a612.8042 _223
245	1	0	_aMitochondrial Mechanisms of Degeneration and Repair in Parkinson's Disease _h[recurso electrónico] / _cedited by Lori M. Buhlman.
264		1	_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2016.
300			_aXII, 275 p. 28 illus., 23 illus. in color. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
505	0		_aMitochondrial ROS and Apoptosis -- Dopamine Metabolism and Reactive Oxygen Species Production -- The Consequences of Damaged Mitochondrial DNA -- The role of chronic inflammation in the etiology of Parkinson?s disease -- Ion-Catalyzed Reactive Oxygen Species in Sporadic Models of Parkinson's Disease -- Toxin Mediated Complex I Inhibition and Parkinson?s Disease -- Parkinson Disease-Associated Mutations Affect Mitochondrial Function -- PARKIN/PINK1 Pathway for the Selective Isolation and Degradation of Impaired Mitochondria -- Mitochondrial Therapeutic approaches in Parkinson's Disease -- Altering Mitochondrial Fusion and Fission Protein Levels Rescues Parkin and PINK1 Loss-of-Function Phenotypes -- Early Nicotine Exposure is Protective in Familial and Idiopathic Models of Parkinson?s Disease -- Transcription Modulation of Mitochondrial Function and Related Pathways as a Therapeutic Opportunity in Parkinson?s Disease -- Delivery of Biologically Active Molecules to Mitochondria.
520			_aThis volume brings together various theories of how aberrations in mitochondrial function and morphology contribute to neurodegeneration in idiopathic and familial forms of Parkinson?s disease. Moreover, it comprehensively reviews the current search for therapies, and proposes how molecules are involved in specific functions as attractive therapeutic targets. It is expected to facilitate critical thought and discussion about the fundamental aspects of neurodegeneration in Parkinson?s disease and foster the development of therapeutic strategies among researchers and graduate students. Theories of idiopathic Parkinson?s etiology support roles for chronic inflammation and exposure to heavy metals or pesticides. Interestingly, as this project proposes, a case can be made that abnormalities in mitochondrial morphology and function are at the core of each of these theories. In fact, the most common approach to the generation of animal and cell-culture models of idiopathic Parkinson?s disease involves exposure to mitochondrial toxins. Even more compelling is the fact that most familial patients harbor genetic mutations that cause disruptions in normal mitochondrial morphology and function. While there remains to be no effective treatment for Parkinson?s disease, efforts to postpone, prevent and ?cure? onset mitochondrial aberrations and neurodegeneration associated with Parkinson?s disease in various models are encouraging. While only about ten percent of Parkinson?s patients inherit disease-causing mutations, discovering common mechanisms by which familial forms of Parkinson?s disease manifest will likely shed light on the pathophysiology of the more common idiopathic form and provide insight to the general process of neurodegeneration, thus revealing therapeutic targets that will become more and more accessible as technology improves.
650		0	_aMedicine.
650		0	_aNeurochemistry.
650		0	_aNeurology.
650		0	_aNeurobiology.
650	1	4	_aBiomedicine.
650	2	4	_aNeurochemistry.
650	2	4	_aNeurobiology.
650	2	4	_aNeurology.
700	1		_aBuhlman, Lori M. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783319421377
856	4	0	_zLibro electrónico _uhttp://148.231.10.114:2048/login?url=http://dx.doi.org/10.1007/978-3-319-42139-1
912			_aZDB-2-SBL
942			_cLIBRO_ELEC
999			_c225567 _d225567